Jinxin Fertility Group Full Year 2024 Earnings: Misses Expectations

Jinxin Fertility Group (HKG:1951) Full Year 2024 Results

Key Financial Results

• Revenue: CN¥2.81b (flat on FY 2023).
• Net income: CN¥283.1m (down 18% from FY 2023).
• Profit margin: 10% (down from 12% in FY 2023).
• EPS: CN¥0.11 (down from CN¥0.13 in FY 2023).

The end of cancer? These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Jinxin Fertility Group Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 7.0%. Earnings per share (EPS) also missed analyst estimates by 32%.

The primary driver behind last 12 months revenue was the Greater China segment contributing a total revenue of CN¥2.21b (79% of total revenue). Notably, cost of sales worth CN¥1.71b amounted to 61% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to CN¥458.0m (56% of total expenses). Explore how 1951's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Healthcare industry in Hong Kong.

Performance of the Hong Kong Healthcare industry.

The company's shares are down 4.5% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Jinxin Fertility Group you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.